Cadart, O.; Mouton, C.; Michelet, M.; Bosc, L.; Pupier, E.; Monsaingeon-Henry, M.; Cherifi, B.
Monitoring of Apixaban in a Super-Obese Patient: Impact of Renal Failure and Topical Application of Econazole. Cardiovasc. Med. 2022, 25, 182.
https://doi.org/10.4414/cvm.2022.02204
AMA Style
Cadart O, Mouton C, Michelet M, Bosc L, Pupier E, Monsaingeon-Henry M, Cherifi B.
Monitoring of Apixaban in a Super-Obese Patient: Impact of Renal Failure and Topical Application of Econazole. Cardiovascular Medicine. 2022; 25(5):182.
https://doi.org/10.4414/cvm.2022.02204
Chicago/Turabian Style
Cadart, Olivier, Christine Mouton, Marie Michelet, Laurène Bosc, Emilie Pupier, Maud Monsaingeon-Henry, and Blandine Cherifi.
2022. "Monitoring of Apixaban in a Super-Obese Patient: Impact of Renal Failure and Topical Application of Econazole" Cardiovascular Medicine 25, no. 5: 182.
https://doi.org/10.4414/cvm.2022.02204
APA Style
Cadart, O., Mouton, C., Michelet, M., Bosc, L., Pupier, E., Monsaingeon-Henry, M., & Cherifi, B.
(2022). Monitoring of Apixaban in a Super-Obese Patient: Impact of Renal Failure and Topical Application of Econazole. Cardiovascular Medicine, 25(5), 182.
https://doi.org/10.4414/cvm.2022.02204
